Acrodermatitis chronica atrophicans historical perspective: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} {{RT}} | {{CMG}}; {{AE}} {{Anahita}} {{RT}} | ||
{{ACA}} | {{ACA}} | ||
==Overview== | ==Overview== | ||
First record of [[acrodermatitis chronica atrophicans]] was made in 1883 in Breslau, Germany, where a [[physician]] named Alfred Buchwald first delineated it. Later in 1902 Herxheimer and Hartmann described it as a "tissue paper" like [[cutaneous]] [[atrophy]]. | |||
==Historical Perspective== | |||
*First record of [[acrodermatitis chronica atrophicans]] was made in 1883 in Breslau, Germany, where a [[physician]] named Alfred Buchwald first delineated it. | |||
*Later in 1902 Herxheimer and Hartmann described it as a "tissue paper" like [[cutaneous]] [[atrophy]]. | |||
*For the first time in 1984, [[borrelia]] was known as the responsible [[etiology]] of [[acrodermatitis chronica atrophicans]].<ref name="pmid9506437">{{cite journal| author=Picken RN, Strle F, Picken MM, Ruzic-Sabljic E, Maraspin V, Lotric-Furlan S | display-authors=etal| title=Identification of three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. garinii, and B. afzelii) among isolates from acrodermatitis chronica atrophicans lesions. | journal=J Invest Dermatol | year= 1998 | volume= 110 | issue= 3 | pages= 211-4 | pmid=9506437 | doi=10.1046/j.1523-1747.1998.00130.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9506437 }} </ref> | |||
==References== | ==References== | ||
Revision as of 18:17, 5 June 2021
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2] Raviteja Guddeti, M.B.B.S. [3]
|
Acrodermatitis chronica atrophicans Microchapters |
|
Differentiating Acrodermatitis chronica atrophicans from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acrodermatitis chronica atrophicans historical perspective On the Web |
|
American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans historical perspective |
|
FDA on Acrodermatitis chronica atrophicans historical perspective |
|
CDC on Acrodermatitis chronica atrophicans historical perspective |
|
Acrodermatitis chronica atrophicans historical perspective in the news |
|
Blogs on Acrodermatitis chronica atrophicans historical perspective |
|
Risk calculators and risk factors for Acrodermatitis chronica atrophicans historical perspective |
Overview
First record of acrodermatitis chronica atrophicans was made in 1883 in Breslau, Germany, where a physician named Alfred Buchwald first delineated it. Later in 1902 Herxheimer and Hartmann described it as a "tissue paper" like cutaneous atrophy.
Historical Perspective
- First record of acrodermatitis chronica atrophicans was made in 1883 in Breslau, Germany, where a physician named Alfred Buchwald first delineated it.
- Later in 1902 Herxheimer and Hartmann described it as a "tissue paper" like cutaneous atrophy.
- For the first time in 1984, borrelia was known as the responsible etiology of acrodermatitis chronica atrophicans.[1]
References
- ↑ Picken RN, Strle F, Picken MM, Ruzic-Sabljic E, Maraspin V, Lotric-Furlan S; et al. (1998). "Identification of three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. garinii, and B. afzelii) among isolates from acrodermatitis chronica atrophicans lesions". J Invest Dermatol. 110 (3): 211–4. doi:10.1046/j.1523-1747.1998.00130.x. PMID 9506437.